Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Roxithromycin (50mg) + Ambroxol (30mg) Tablet
Therapeutic Category
Pulmonary, Respiratory
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Roxyfoli AM 30 Tablet containing Roxithromycin and Ambroxol is used for the management of respiratory tract infections associated with cough and mucus production. It helps support infection control and respiratory comfort.
Roxithromycin works as a macrolide antibiotic that inhibits bacterial growth, while Ambroxol acts as a mucolytic agent that helps loosen and clear mucus from the respiratory tract.
The tablet is widely prescribed in respiratory and general medicine practice for chest infections with productive cough, leading to consistent prescription demand.
With increasing prevalence of respiratory infections and seasonal chest congestion disorders, this product offers strong business potential for retailers and distributors. Its dual therapeutic action, broad clinical relevance, and steady market demand make it a reliable product for growth in the respiratory segment.
Some patients may experience nausea, abdominal discomfort, diarrhea, headache, dizziness, or altered taste. Rarely, allergic reactions, liver enzyme abnormalities, or cardiac rhythm disturbances may occur and require medical attention.
Roxyfoli AM 30 Tablet is indicated for respiratory tract infections such as bronchitis, sinusitis, pharyngitis, tonsillitis, and other bacterial infections associated with mucus congestion. It helps control bacterial growth, reduce cough with mucus, improve airway clearance, and support faster recovery.
This medicine should be used under medical supervision. Complete the full prescribed course to avoid antibiotic resistance. Use cautiously in patients with liver disorders or cardiac conditions.
Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.
Composition : Acebrophylline (100mg) Capsule
Composition : Doxofylline (400mg) + Acebrophylline (100mg)
Composition : Acebrophylline (200mg) + Desloratadine (5mg) + Montelukast (10mg) Tablet
Composition : Levosalbutamol (1.25mg) + Ipratropium (500mcg)
Composition : Acebrophylline (200mg) + Montelukast (10mg)
Composition : Montelukast (10mg) + Fexofenadine (120mg) + Acebrophylline (200mg) (Sustained Release)
Composition : Acebrophylline (50mg) Syrup
Composition : Terbutaline (1.25mg/5ml) + Acebrophylline (50mg/5ml) + Guaifenesin (50mg/5ml) Syrup
Composition : Bilastin (20mg ) + Montelukast (10mg) + Acebrophylline (200mg) Sr Tab
Composition : Bilastine (10mg) + Acebrophylline (200mg) Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Roxyfoli AM 30 Tablet, containing Roxithromycin 50mg and Ambroxol 30mg, has strong demand in the respiratory and anti-infective segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on chest care and infection management portfolios.
Medical distributors and agencies can benefit from the consistent demand for combination therapies used in respiratory tract infections associated with cough, mucus congestion, and bacterial infections. The combination of antibiotic and mucolytic support helps strengthen a comprehensive respiratory care product portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Roxyfoli AM 30 Tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong seasonal prescription demand, reliable supply chain support, fast-moving respiratory care sales, and good margins when partnering for Roxyfoli AM 30 Tablet distribution.
Medical distributors, stockists, and wholesalers interested in Roxyfoli AM 30 Tablet can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.